PapersPMID:35684079
Consumption of Low Dose Fucoxanthin Does Not Prevent Hepatic and Adipose Inflammation and Fibrosis in Mouse Models of Diet-Induced Obesity.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →- No detected effect on alanine aminotransferase
insufficient
“No significant differences were present in liver triglyceride and total cholesterol, hepatic fat accumulation, and serum alanine aminotransferase levels between control and FCX-fed mice regardless of whether they were on an HFC or HFS diet.”
- Study
- animal · not in humans
- Dose studied
- 0.015% or 0.03% w/w FCX in HFC diet, 12 weeks; 0.01% w/w FCX in HFS diet, 8 weeks
- Population
- C57BL/6J mice, pooled across HFC (high-fat/high-sucrose/high-cholesterol) and HFS (high-fat/high-sucrose) diet-induced obesity models, FCX-supplemented diet vs same diet without FCX
Study record
- Design
- animal study, in vivo
- Species
- animal
- Population
- C57BL/6J mice, two diet-induced obesity (DIO) models: HFC diet (high-fat/high-sucrose/high-cholesterol, NASH-inducing) for 12 weeks, or HFS diet (high-fat/high-sucrose) for 8 weeks
- Participants
- not reported
- Comparator
- not stated in the paper / placebo
- Duration
- not reported
- Endpoints measured
- 6